{
  "text": "Methsuximide for intractable childhood seizures.\n Methsuximide was added to the therapeutic regimens of 25 children with intractable epilepsy.\n In 15 patients the drug was well tolerated and resulted in a 50% or greater reduction in seizure frequency.\n No serious or irreversible adverse effects were seen.\n Methsuximide is frequently overlooked and may be an effective adjunctive antiepileptic for children with intractable seizures.",
  "category": "C10"
}